Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Robert Fitzgibbons

Surgery Omaha, NE Medical Doctor

NPI 1437264124 CMS profile 111016

7710 Mercy Rd Ste 2000, Omaha, NE 68124

Open in the dashboard

General payments

$5,967

69 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Robert Fitzgibbons of Omaha, NE is reported in the CMS Open Payments database as having received $5,967 across 69 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $150 1
2023 General $199 9
2022 General $738 19
2021 General $830 11
2020 General $192 8
2019 General $3,858 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Fitzgibbons
  • Surgery median
  • Middle half of Surgery
  • National median

In program year 2025, general payments to Robert Fitzgibbons were reported at $0. Among 17,702 Surgery profiles paid that year, the median was $280 and the middle half received between $91 and $1,259.

Show as a table
Year Robert Fitzgibbons Surgery median Middle half National median
2019 $3,858 $253 $82–$1,521 $163
2020 $192 $131 $40–$706 $114
2021 $830 $168 $50–$904 $132
2022 $738 $224 $76–$1,218 $149
2023 $199 $253 $82–$1,255 $160
2024 $150 $279 $90–$1,381 $164
2025 $0 $280 $91–$1,259 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Intuitive Surgical, Inc. $3,234 4 payments
  2. Davol Inc. $723 15 payments
  3. Musculoskeletal Transplant Foundation Inc. $455 1 payment
  4. Innocoll Incorporated $319 5 payments
  5. Integra LifeSciences Corporation $201 3 payments
  6. Olympus America Inc. $165 3 payments
  7. TELA Bio, Inc. $137 8 payments
  8. Smith+Nephew, Inc. $93 3 payments
  9. Covidien LP $89 1 payment
  10. CONMED Corporation $63 1 payment
  11. Other $489 25 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Education $3,000 1 payment
  2. Food and Beverage $2,967 68 payments
Products named General payments · program years 2019–2024
  1. Da Vinci Surgical System $3,234 4 payments
  2. PHASIX $391 7 payments
  3. XARACOLL $301 4 payments
  4. Integra Recon-Skin And Wound $201 3 payments
  5. Integra Recon-Skin And Wound $201 3 payments
  6. Integra Recon-Skin And Wound $201 3 payments
  7. INTEGRA DERMAL REGENERATION TEMPLATE $201 3 payments
  8. PRIMATRIX $201 3 payments
  9. EVIS EXERA $130 1 payment
  10. Olympus Laparoscopic Accessories $130 1 payment
  11. Other $1,142 53 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$857

Medicare's payments for the services billed

Medicare patients

19

Average age 72

Services billed

30

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

69 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Surgery in Nebraska

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record